High-throughput techniques in breast cancer: A clinical perspective
- 31 March 2006
- journal article
- review article
- Published by Elsevier in European Journal Of Cancer
- Vol. 42 (5) , 598-607
- https://doi.org/10.1016/j.ejca.2005.11.021
Abstract
No abstract availableKeywords
This publication has 75 references indexed in Scilit:
- Genetic losses in breast cancer: toward an integrated molecular cytogenetic mapCancer Genetics and Cytogenetics, 2005
- High‐throughput protein expression analysis using tissue microarray technology of a large well‐characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analysesInternational Journal of Cancer, 2005
- Molecular mechanisms of drug resistanceThe Journal of Pathology, 2005
- A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast CancerNew England Journal of Medicine, 2004
- Genomic and proteomic technologies for individualisation and improvement of cancer treatmentEuropean Journal Of Cancer, 2004
- Prediction of Survival in Diffuse Large-B-Cell Lymphoma Based on the Expression of Six GenesNew England Journal of Medicine, 2004
- Repeated observation of breast tumor subtypes in independent gene expression data setsProceedings of the National Academy of Sciences, 2003
- Mass spectrometry-based proteomicsNature, 2003
- A Gene-Expression Signature as a Predictor of Survival in Breast CancerNew England Journal of Medicine, 2002
- Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implicationsProceedings of the National Academy of Sciences, 2001